Abstract
To investigate the availability of essential medicines and their prices in Hubei province. The survey assessed the prices and availability of essential medicines using the World Health Organization and Health Action International methodology. Data were collected from 18 public hospitals and 18 private pharmacies. At each facility the availability and prices of 39 innovator brand medicines and lowest-price generic equivalent medicines were collected. Medicine prices were compared with international reference prices to obtain a median price ratio (MPR). Daily incomes of low and average levels were used to assess the affordability of the medicines. Median availability in the public and private sectors was low (38.9% and 44.4% for lowest-price generics, respectively). The median MPRs of procurement prices for innovator brands and lowest-price generics in the public sector were 9.78 and 0.74 times the international reference prices; and the median MPRs of retail prices to patients for lowest-price generics in the public sector (1.04) were higher than those in the private sector (0.68). For most of the population, the medicine prices are affordable, but for those of low income they are not. The survey revealed low procurement prices but poor availability in the public sector. Various policy adjustments could increase the availability of essential medicines and reduce their prices for the low income population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
